5 episodes

What’s exciting, new and interesting in biology & life sciences? IndieBio partner Gwen Cheni speaks with founders, VCs and scientists to find out.

The IndieBio Podcast aims to be a resource to the biotech community, with the guest speakers being approximately one-third VCs, one-third founders, and one-third scientists and engineers. We hope to keep you entertained, while making you think.

SOSV's IndieBio enables the world’s best scientists to build radically innovative companies. This show is for scientists, entrepreneurs, investors, dreamers & doers who want to build the future.

More details, transcripts and info about IndieBio and SOSV at:
linktr.ee/indiebio

The IndieBio Podcast Gwen Cheni

    • Science

What’s exciting, new and interesting in biology & life sciences? IndieBio partner Gwen Cheni speaks with founders, VCs and scientists to find out.

The IndieBio Podcast aims to be a resource to the biotech community, with the guest speakers being approximately one-third VCs, one-third founders, and one-third scientists and engineers. We hope to keep you entertained, while making you think.

SOSV's IndieBio enables the world’s best scientists to build radically innovative companies. This show is for scientists, entrepreneurs, investors, dreamers & doers who want to build the future.

More details, transcripts and info about IndieBio and SOSV at:
linktr.ee/indiebio

    A Family Tradition In Biotech

    A Family Tradition In Biotech

    In this sesh, we chat with Michael Langer, son of the famed Professor Bob Langer, who is continuing the family tradition of investing in innovative biotech companies.

    • 28 min
    Speed As A Superpower

    Speed As A Superpower

    In this episode, we interview the new General Partner at NFX Bio, Omri Amirav-Drory, and long-time mentor at IndieBio. Omri was previously the founder of Tech.bio and Genome Compiler (acquired by Twist).

    • 38 min
    Solve for Series A Data at Seed

    Solve for Series A Data at Seed

    In this session, we interview Gianna from Xontogeny, a therapeutics focused seed-stage VC fund founded by Chris Garabedian, former CEO of Sarepta.

    • 36 min
    How to CSO a Unicorn - Pablo Zamora, PhD. Co-Founder of NotCo

    How to CSO a Unicorn - Pablo Zamora, PhD. Co-Founder of NotCo

    Gwen speaks with Pablo Zamora, Co-Founder and original CSO of NotCo. From their website: "When we discovered removing animals from food production would protect the planet, the solution was simple: create an algorithm - that we named Giuseppe - who could learn infinite combinations of plants to replicate animal products, make them sustainable and taste even better.
    Now, for the sake of the planet, let’s reinvent the food industry — one delicious mouthful at a time."

    • 51 min
    The New Era of Biotech VCs

    The New Era of Biotech VCs

    Our inaugural VC guest is Shahram Seyedin-Noor, founder and General Partner at Civilization Ventures. Shahram was trained as a lawyer, and worked on the business side of several bio startups, before focusing on investing.




    More details, transcripts and info about IndieBio and SOSV at: linktr.ee/indiebio
     



    Note: Pillo and Kit were mentioned in error. Civilization Ventures' co-investments with SOSV are: Catalog (IBSF 04), Prellis Biologics (IBSF Batch 05), and r-zero (HAX Seed 2020)
      


    About IndieBio


    Each startup team receives $525,000 in seed funding, lab and co-working space, dedicated mentorship, and become part of a huge network of IndieBio alumni, investors, biotech entrepreneurs, investors, press, corporate partners, and more.


     


    SOSV’s IndieBio has large laboratories and co-working space both in downtown San Francisco and New York City that our startups come to as hubs for their activities. We also now support companies remotely, from any location that’s optimal for the startup.


     


    All startups are trained (in-person or remote) through an intense 4-month program unlike anything they’ve ever experienced in their PhD’s and Post-doctoral training. Founders engage with customers and partners, pitch to investors, and turn science into a real product people pay for. Both locations run 2 programs with 15 companies each year.

    • 44 min